Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects
Recruiting
Phase 1
Interventional Study
Depression - Major Depressive Disorder
Anhedonia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 55
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 85 (estimated)
- Sponsor
- Medical University of Vienna · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to systematically categorize potential prohedonic effects of psilocybin in patients with anhedonia in depression. The main questions it aims to answer are:
Primary Objectives
1. Systematically categorize prohedonic effects (antianhedonic effects in patients with anhedonia in depression, increase in well-being in all participants).
2. Test effects of psilocybin …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria:
All participants:
* General health based on medical history, physical examination, blood draw, and electrocardiogram
* Age 18 to 55 years
* Right-handedness (due to potential lateralization effects of left-handed subjects)
* Willingness and competence to sign the informed conse…
Contacts